Merck Company – Consensus Indicates Potential 19.3% Upside
Merck Company found using ticker (MRK) have now 20 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 125 and 85 with the average target price sitting at 100.85. With the stocks previous close at 84.53 this is indicating there is a potential upside of 19.3%. The day 50 moving average is 88.99 and the 200 moving average now moves to 84.66. The company has a market cap of $221,687m. Company Website: https:||www.merck.com [stock_market_widget type="chart" template="basic" color="green" assets="MRK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $264,488m based on the market concensus. Merck Co. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines.
Merck Company – Consensus Indicates Potential 19.3% Upside
Merck Company found using ticker (MRK) have now 20 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 125 and 85 with the average target price sitting at 100.85. With the stocks previous close at 84.53 this is indicating there is a potential upside of 19.3%. The day 50 moving average is 88.99 and the 200 moving average now moves to 84.66. The company has a market cap of $221,687m. Company Website: https:||www.merck.com [stock_market_widget type="chart" template="basic" color="green" assets="MRK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $264,488m based on the market concensus. Merck Co. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines.